A Phase I Randomised, Double-Blind, Placebo-Controlled, Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Food Effect of WD-910 in Healthy Participants

NCT06897813 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

68

Enrollment

OTHER

Sponsor class

Conditions

Healthy Participants

Interventions

DRUG: WD-910 tablet
DRUG: WD-910 Tablets Placebo

Sponsor

Zhejiang Wenda Pharma Technology LTD.